Cite
HARVARD Citation
Ledermann, J. et al. (n.d.). LBA36Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study. Annals of oncology. p. . [Online].